UBS AM’s CAMP4 Therapeutics CAMP Stock Holding History
Bought
Maintained
Sold
Other funds holding CAMP
UBS AM's CAMP Position: Q3 2026 in Review
UBS AM opened a new position in CAMP4 Therapeutics (CAMP) in Q3 2026: 242 shares worth $978. The stake represents ﹤0.01% of the portfolio and ranks #4126 among its holdings.
50 funds tracked by Wall St. Rank hold CAMP as of Q3 2026.
- UBS AM held 242 shares of CAMP4 Therapeutics worth $978 as of Q3 2026.
- CAMP4 Therapeutics was a new UBS AM position in Q3 2026.
- CAMP4 Therapeutics made up ﹤0.01% of UBS AM's portfolio in Q3 2026, its #4126 holding.
- 50 funds tracked by Wall St. Rank held CAMP4 Therapeutics as of Q3 2026.
Based on UBS AM's 13F filing for Q3 2026, filed 16 Nov 2026.